Novel Laboratories (Rights to Generic Version of HalfLytely) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Novel Laboratories (Rights to Generic Version of HalfLytely) General Information

Description

Pharmaceutical rights of Tablets. It contains rights for preparation of tablets for the cleansing of the colon as a preparation for colonoscopy in adults.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Primary Office
  • 400 Campus Drive
  • Somerset, NJ
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novel Laboratories (Rights to Generic Version of HalfLytely) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novel Laboratories (Rights to Generic Version of HalfLytely)‘s full profile, request access.

Request a free trial

Novel Laboratories (Rights to Generic Version of HalfLytely) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novel Laboratories (Rights to Generic Version of HalfLytely)‘s full profile, request access.

Request a free trial